Skip to main content
Figure 2 | Cardiovascular Diabetology

Figure 2

From: Azelnidipine prevents cardiac dysfunction in streptozotocin-diabetic rats by reducing intracellular calcium accumulation, oxidative stress and apoptosis

Figure 2

Intracellular Ca2+ transient properties of ventricular myocytes isolated from control, diabetic rats and diabetic rats treated with AZL (5 mg kg-1 day-1). A: Baseline intracellular Ca2+ concentrations; B: Increase in intracellular Ca2+ transient in response to electrical stimulus; C: rate of cytosolic free Ca2+ decrease (Tau). Values are means ± SEM; n = 104 to 126/group. *P < 0.05 vs. control group; **P < 0.05 vs. diabetic group.

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840